COVID-19

Newest Oldest Showing 41-45 of 45 results
Case Report / VOLUME 2, ISSUE 1, APRIL 2020

Adverse Cardiac Events Related to Hydroxychloroquine Prophylaxis and Treatment of COVID-19

Rehile Zengin and others

Hydroxychloroquine is commonly used for the treatment of rheumatic diseases because of its antinflammatory effects. It is a 4-amino-quinoline that is widely used for the treatment purposes. The Scientific Advisory Board of Ministry of Health of Turkey for COVID-19 recommends HCQ for treatment and also for prophylactic use of COVID-19. Infectious Diseases Society of America (IDSA) suggested the HCQ but also warned Read More

Review Article / VOLUME 2, ISSUE 1, APRIL 2020

Policy Analysis of Suppression and Mitigation Strategies in the Management of an Outbreak Through the Example of COVID-19 Pandemic

İlker Kayı and Sibel Sakarya

In the statement he gave to the television program Nieuwsuuer on March 16, Sunday evening, the Head of Dutch National Institute for Public Health and the Environment (RIVM) Jaap van Dissel maintained that ‘an approach of total lockdown would lead the COVID-19 to bounce back’ and thereby they would employ the ‘maximum control’ strategy. Read More

Review Article / VOLUME 2, ISSUE 1, APRIL 2020

Mental Health Consequences of COVID-19 Disaster

Gamze Özçürümez Bilgili

Disasters are large-scale events that are often unexpected and cause death, trauma, and destruction of property. Although there is no consistent definition of disasters in the literature, researchers generally agree that disasters share three key characteristics of large-scale traumatic events. First, disasters threaten to harm or death to a large group of people, Read More

Commentary / VOLUME 2, ISSUE 1, APRIL 2020

Clinical Management of COVID-19: Conceptual Framework

Jordi Rello and Ricardo Serrano

In the treatment of COVID-19, attention is focused on expensive, high technology equipment such as sophisticated ventilators or extracorporeal membrane oxygenation (ECMO), which requires highly trained health care workers and aggressive pharmacological measures with weak evidence of efficacy. Read More

Commentary / VOLUME 2, ISSUE 1, APRIL 2020

Being a COVID-19 Patient as an Infectious Diseases Physician

Mahir Kapmaz

This paper is dedicated to the memory of legendary clinician, Professor Cemil Taşçıoğlu who succumbed to COVID-19. I am an Infectious Diseases and Clinical Microbiology physician. We were at the frontline of the battle of COVID-19 soon after the first case in Turkey, that was officially declared on 11 March 2020. Rick Penciner was a […] Read More